Unisom SleepTabs deliver clinically validated sleep onset acceleration through 25mg of doxylamine succinate, a first-generation antihistamine with well-established hypnagogic properties. Pharmacokinetic studies demonstrate approximately 33% reduction in sleep latency compared to placebo, facilitating faster transition into restorative sleep stages. The non-habit-forming formulation permits extended use...